Yvonne Mårtensson has vast industrial experience in executive management and board director work. Her experience from the healthcare area, specially medical technology and diagnostics, includes executive positions in international marketing, sales and general board director work in fast growing high technology companies. She also has experience from venture capital investment in Suntone Life Science Ventures.
As a CEO for CellaVision AB, 1998-2014, a company within hematology diagnostics using imaging analysis, she managed to take the company from a technical idea to an international well positioned company on the Nasdaq Stockholm.
She holds an MSc in Industrial Engineering from University of Linköping, Sweden.
Year of birth: 1953
Elected to the board: May 2023
Shares: 10,000 Stock options: 0